Dasatinib Pharmascience 100 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dasatinib pharmascience 100 mg filmom obložene tablete

pharmascience international limited, lampousas, 1, nicosia, cipar - дазатиниб - filmom obložena tableta - 100 mg - urbroj: jedna filmom obložena tableta sadrži 100 mg dasatiniba (bezvodni oblik)

Dasatinib Pharmascience 140 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dasatinib pharmascience 140 mg filmom obložene tablete

pharmascience international limited, lampousas, 1, nicosia, cipar - дазатиниб - filmom obložena tableta - 140 mg - urbroj: jedna filmom obložena tableta sadrži 140 mg dasatiniba (bezvodni oblik)

Dasatinib Pharmascience 20 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dasatinib pharmascience 20 mg filmom obložene tablete

pharmascience international limited, lampousas, 1, nicosia, cipar - дазатиниб - filmom obložena tableta - 20 mg - urbroj: jedna filmom obložena tableta sadrži 20 mg dasatiniba (bezvodni oblik)

Dasatinib Pharmascience 50 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dasatinib pharmascience 50 mg filmom obložene tablete

pharmascience international limited, lampousas, 1, nicosia, cipar - дазатиниб - filmom obložena tableta - 50 mg - urbroj: jedna filmom obložena tableta sadrži 50 mg dasatiniba (bezvodni oblik)

Dasatinib Pharmascience 70 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dasatinib pharmascience 70 mg filmom obložene tablete

pharmascience international limited, lampousas, 1, nicosia, cipar - дазатиниб - filmom obložena tableta - 70 mg - urbroj: jedna filmom obložena tableta sadrži 70 mg dasatiniba (bezvodni oblik)

Dasatinib Pharmascience 80 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dasatinib pharmascience 80 mg filmom obložene tablete

pharmascience international limited, lampousas, 1, nicosia, cipar - дазатиниб - filmom obložena tableta - 80 mg - urbroj: jedna filmom obložena tableta sadrži 80 mg dasatiniba (bezvodni oblik)

Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Europska Unija - hrvatski - EMA (European Medicines Agency)

clopidogrel taw pharma (previously clopidogrel mylan)

taw pharma (ireland) limited - klopidogrel hidroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotska sredstva - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Cegfila (previously Pegfilgrastim Mundipharma) Europska Unija - hrvatski - EMA (European Medicines Agency)

cegfila (previously pegfilgrastim mundipharma)

mundipharma corporation (ireland) limited - pegfilgrastim - neutropenija - Иммуностимуляторы, - smanjenje duljine trajanja neutropenije i incidencije febrilne neutropenije u odraslih bolesnika liječenih citotoksičnom kemoterapijom zbog zloćudne bolesti (uz iznimku kronične mijeloične leukemije i mijelodisplastičnog sindroma).

Teriflunomid Pharmascience 14 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

teriflunomid pharmascience 14 mg filmom obložene tablete

pharmascience international limited, lampousas, 1, nicosia, cipar - teriflunomid - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 14 mg teriflunomida

Fingolimod Pharmascience 0,5 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

fingolimod pharmascience 0,5 mg tvrde kapsule

pharmascience international limited, lampousas, 1, nicosia, cipar - fingolimodklorid - kapsula, tvrda - urbroj: jedna kapsula sadrži 0,5 mg fingolimoda (u obliku fingolimodklorida)